2019 ESPN临床实践建议:儿童慢性肾病患者生长激素治疗

2019-06-13 欧洲儿科肾脏病学会 Nat Rev Nephrol. 2019 Jun 13.

2019年6月,欧洲儿科肾脏病学会(ESPN)慢性肾病矿物质和骨病、透析和移植工作组发布了儿童慢性肾病患者生长激素治疗建议。在慢性肾脏病儿童患者中实现正常的生长是临床具有挑战的问题之一,在慢性肾脏病儿童患者中实现正常的生长是临床具有挑战的问题之一。应用重组人生长激素(GH)治疗可促进纵向生长,令这里患者达到正常生。本文主要针对儿童慢性肾病患者生长激素治疗的相关内容提出指导建议。

中文标题:

2019 ESPN临床实践建议:儿童慢性肾病患者生长激素治疗

英文标题:

Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease.

发布机构:

欧洲儿科肾脏病学会

发布日期:

2019-06-13

简要介绍:

2019年6月,欧洲儿科肾脏病学会(ESPN)慢性肾病矿物质和骨病、透析和移植工作组发布了儿童慢性肾病患者生长激素治疗建议。在慢性肾脏病儿童患者中实现正常的生长是临床具有挑战的问题之一,在慢性肾脏病儿童患者中实现正常的生长是临床具有挑战的问题之一。应用重组人生长激素(GH)治疗可促进纵向生长,令这里患者达到正常生。本文主要针对儿童慢性肾病患者生长激素治疗的相关内容提出指导建议。 

拓展指南:慢性肾病相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 ESPN临床实践建议:儿童慢性肾病患者生长激素治疗)] GetToolGuiderByIdResponse(projectId=1, id=3750a1c001e5108f, title=2019 ESPN临床实践建议:儿童慢性肾病患者生长激素治疗, enTitle=Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease., guiderFrom=Nat Rev Nephrol. 2019 Jun 13., authorId=null, author=, summary=2019年6月,欧洲儿科肾脏病学会(ESPN)慢性肾病矿物质和骨病、透析和移植工作组发布了儿童慢性肾病患者生长激素治疗建议。在慢性肾脏病儿童患者中实现正常的生长是临床具有挑战的问题之一,在慢性肾脏病儿童患者中实现正常的生长是临床具有挑战的问题之一。应用重组人生长激素(GH)治疗可促进纵向生长,令这里患者达到正常生。本文主要针对儿童慢性肾病患者生长激素治疗的相关内容提出指导建议。 , cover=, journalId=null, articlesId=null, associationId=1099, associationName=欧洲儿科肾脏病学会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Jun 13 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年6月,欧洲儿科肾脏病学会(ESPN)慢性肾病矿物质和骨病、透析和移植工作组发布了儿童慢性肾病患者生长激素治疗建议。在慢性肾脏病儿童患者中实现正常的生长是临床具有挑战的问题之一,在慢性肾脏病儿童患者中实现正常的生长是临床具有挑战的问题之一。应用重组人生长激素(GH)治疗可促进纵向生长,令这里患者达到正常生。本文主要针对儿童慢性肾病患者生长激素治疗的相关内容提出指导建议。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>慢性肾病</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=ac0e21c001ea6989" title="2019 AIOM/SIN共识意见:慢性肾病或血液透析的癌症患者的靶向治疗管理" target=_blank>2019 AIOM/SIN共识意见:慢性肾病或血液透析的癌症患者的靶向治疗管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=392f01c001e3688d" title="2019 接受肾脏保守治疗患者的护理建议:慢性肾病及症状的管理" target=_blank>2019 接受肾脏保守治疗患者的护理建议:慢性肾病及症状的管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=6fb471c001e1381a" title="2019 接受肾脏保守治疗患者的护理建议-聚焦慢性肾病和症状的管理" target=_blank>2019 接受肾脏保守治疗患者的护理建议-聚焦慢性肾病和症状的管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=9032c1c001a910b0" title="2017 NICE诊断指南:多频生物电阻抗装置指导慢性肾病患者进行血液透析时的液体管理(DG.29)" target=_blank>2017 NICE诊断指南:多频生物电阻抗装置指导慢性肾病患者进行血液透析时的液体管理(DG.29)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=20bf51c001ae2321" title="2016共识声明:患有糖尿病和慢性肾病患者应用抗糖尿病药物的剂量调整" target=_blank>2016共识声明:患有糖尿病和慢性肾病患者应用抗糖尿病药物的剂量调整</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E6%85%A2%E6%80%A7%E8%82%BE%E7%97%85" target=_blank>有关慢性肾病更多指南</a></ul>, tagList=[TagDto(tagId=91351, tagName=儿童慢性肾病), TagDto(tagId=63562, tagName=生长激素治疗)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6360, appHits=145, showAppHits=0, pcHits=4341, showPcHits=3171, likes=83, shares=3, comments=4, approvalStatus=1, publishedTime=Sun Jun 23 23:24:41 CST 2019, publishedTimeString=2019-06-13, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Jun 23 23:24:41 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 10:38:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 ESPN临床实践建议:儿童慢性肾病患者生长激素治疗)])
2019 ESPN临床实践建议:儿童慢性肾病患者生长激素治疗
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1227495, encodeId=dcce122e49561, content=谢谢呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/043c416ade284b67b8bafaff23e16162/d7e89053b7404d398b8a44898debdf2d.jpg, createdBy=8c102549666, createdName=七七鱼, createdTime=Mon Jun 20 09:53:26 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954818, encodeId=4b30954818e5, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6fa5477764, createdName=ms1000000063568065, createdTime=Wed Apr 07 15:26:09 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368243, encodeId=face368243be, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Mon Jun 24 06:13:42 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
    2022-06-20 七七鱼

    谢谢呀

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1227495, encodeId=dcce122e49561, content=谢谢呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/043c416ade284b67b8bafaff23e16162/d7e89053b7404d398b8a44898debdf2d.jpg, createdBy=8c102549666, createdName=七七鱼, createdTime=Mon Jun 20 09:53:26 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954818, encodeId=4b30954818e5, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6fa5477764, createdName=ms1000000063568065, createdTime=Wed Apr 07 15:26:09 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368243, encodeId=face368243be, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Mon Jun 24 06:13:42 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
    2021-04-07 ms1000000063568065

    好文章

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1227495, encodeId=dcce122e49561, content=谢谢呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/043c416ade284b67b8bafaff23e16162/d7e89053b7404d398b8a44898debdf2d.jpg, createdBy=8c102549666, createdName=七七鱼, createdTime=Mon Jun 20 09:53:26 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954818, encodeId=4b30954818e5, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6fa5477764, createdName=ms1000000063568065, createdTime=Wed Apr 07 15:26:09 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368243, encodeId=face368243be, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Mon Jun 24 06:13:42 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
    2019-06-24 百草

    666

    1

    展开1条回复